首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1544754

基因檢測市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Genetic Testing Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年07月03日 | 出版商:

Global Market Insights Inc. | 英文 276 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於基因組技術的不斷推出和進步，2024 年至 2032 年全球基因檢測市場規模將以 11.7% 的複合年成長率擴大。

最近，醫療保健產業見證了新的測試解決方案的推出，這些解決方案的準確性更高，並且在醫療保健、個人化醫療和研究方面的應用不斷擴大。此外，創新還結合了下一代定序技術和改進的資料分析工具，以提供更深入的遺傳見解。例如，2024 年 3 月，BillionToOne 推出了 BabyPeek，這是一種產前基因測試，可提供有關嬰兒的非醫學見解，例如潛在的眼睛顏色、頭髮質地和食物偏好。這項發展凸顯了基因檢測技術在個人化見解方面所取得的進展。

市場分為產品和服務、測試類型、應用、技術、最終用途和區域。

在產品和服務方面，預計到 2032 年，軟體和服務領域的基因檢測產業佔有率將大幅成長。隨著軟體開發人員精心設計先進的遺傳分析工具，遺傳服務提供者正在提供對遺傳傾向和性狀的更深入的見解。這種協同作用簡化了遺傳資料的解釋，使其更加方便用戶使用和可操作。

就最終用途而言，診斷實驗室領域的基因檢測市場價值預計將在 2024 年至 2032 年期間成長。透過利用先進的演算法和資料分析工具，診斷實驗室正在提高遺傳結果的準確性和速度。基因檢測及其相關技術的不斷發展為診斷實驗室持續提供增強和個性化的健康見解鋪平了道路。

從地區來看，亞太地區基因檢測產業預計在 2024 年至 2032 年間將出現顯著的複合年成長率，這主要是由癌症發生率不斷上升的推動。隨著癌症滲透率的激增，對基因檢測的需求不斷增加，以查明遺傳風險並客製化治療計劃。因此，持續的創新旨在提供徹底的癌症風險評估和量身定做的管理策略，根據該地區不斷上升的癌症發病率提高結果並支持積極的醫療保健措施。

產業生態系統分析
產業影響力
- 成長動力
  - 技術進步和新測試的可用性
  - 基因檢測在腫瘤學和遺傳疾病的應用日益廣泛
  - 消費者對個人化醫療的偏好不斷增加
  - 對直接面對消費者的基因檢測的需求不斷成長
- 產業陷阱與挑戰
  - 基因檢測費用高
  - 發展中經濟體和已開發經濟體缺乏經驗豐富的專業人員和先進的基礎設施
成長潛力分析
監管環境
技術景觀
報銷場景
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品和服務分類，2021 - 2032 年

主要趨勢
試劑盒和試劑
軟體和服務

第 6 章：市場估計與預測：按測試類型，2021 - 2032 年

主要趨勢
預測測試
營運商測試
產前和新生兒檢測
診斷測試
藥物基因組測試
營養基因體學
其他測試類型

第 7 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
癌症治療
移植組織分型
法醫身分測試
血統測試
親子鑑定
其他應用

第 8 章：市場估計與預測：按技術分類，2021 - 2032 年

主要趨勢
聚合酶鍊式反應
DNA定序
- 桑格定序
- 下一代定序
細胞遺傳學檢測
- 染色體分析（核型分析）
- 螢光原位雜合技術（FISH）
微陣列
基因表現譜

第 9 章：市場估計與預測：依最終用途，2021 - 2032 年

主要趨勢
醫院和診所
診斷實驗室
法醫實驗室
其他最終用戶

第 10 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 11 章：公司簡介

23 and ME, Inc.
Abbott Laboratories
Ambry genetics
Ancestry DNA
bioMerieux SA
BGI Genomics
Eurofins Scientific
Illumina, Inc.
Invitae Corporation
Luminex Corporation
Myriad Genetics, Inc.
Natera, Inc.
QIAGEN N.V.
Quest Diagnostics
Siemens Healthineers AG

簡介目錄

Product Code: 2490

Global Genetic Testing Market size will expand at an 11.7% CAGR from 2024 to 2032, due to increasing launches and advancements in genomic technology.

Recently, the healthcare sector has witnessed the introduction of new testing solutions with enhanced accuracy and expanding applications in healthcare, personalized medicine, and research. Furthermore, innovations are incorporating next-generation sequencing technologies and refining data analysis tools to deliver deeper genetic insights. For example, in March 2024, BillionToOne unveiled BabyPeek, a prenatal genetic test that offers non-medical insights about the baby, such as potential eye color, hair texture, and food preferences. This development underscores the strides made in genetic testing technology for personalized insights.

The market is segregated into product and service, test type, application, technique, end-use, and region.

In terms of product and service, the genetic testing industry share from the software and services segment is expected to witness growth at a significant rate through 2032. This is fuelled by the increasing demand for a transformative approach to health management. As software developers craft advanced genetic analysis tools, genetic service providers are delivering deeper insights into genetic predispositions and traits. This synergy simplifies the interpretation of genetic data, making it more user-friendly and actionable.

In terms of end-use, the genetic testing market value from the diagnostic laboratories segment is anticipated to grow from 2024 to 2032. This is attributed to the push for advanced genetic testing through the adoption of state-of-the-art technologies and software solutions. By leveraging advanced algorithms and data analysis tools, diagnostic laboratories are boosting the accuracy and speed of genetic results. The continuous evolution in genetic testing and its associated technologies is paving the way for diagnostic laboratories to consistently offer enhanced and personalized health insights.

Regionally, the Asia Pacific genetic testing industry is set to experience a notable CAGR between 2024 and 2032, primarily driven by the escalating incidence of cancer. With this surging cancer penetration, there is an increasing demand for genetic testing to pinpoint hereditary risks and customize treatment plans. Consequently, the ongoing innovations aim to provide thorough cancer risk evaluations and tailored management strategies, enhancing outcomes and bolstering proactive healthcare measures in light of the rising cancer rates in the region.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Technological advancement and availability of new tests
  - 3.2.1.2 Growing application of genetic testing in oncology and genetic diseases
  - 3.2.1.3 Increasing consumer preference for personalized medicine
  - 3.2.1.4 Growing demand for direct-to-consumer genetic testing
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of genetic testing
  - 3.2.2.2 Dearth of experienced professionals and advanced infrastructure in developing and developed economies
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Reimbursement scenario
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product and Service, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Kits and reagents
5.3 Software and services

Chapter 6 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Predictive testing
6.3 Carrier testing
6.4 Prenatal and newborn testing
6.5 Diagnostic testing
6.6 Pharmacogenomic testing
6.7 Nutrigenomics
6.8 Other test types

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Cancer treatment
7.3 Tissue typing for transplantation
7.4 Forensic identity testing
7.5 Ancestry testing
7.6 Paternity testing
7.7 Other applications

Chapter 8 Market Estimates and Forecast, By Technique, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Polymerase chain reaction
8.3 DNA sequencing
- 8.3.1 Sanger sequencing
- 8.3.2 Next generation sequencing
8.4 Cytogenetic testing
- 8.4.1 Chromosome analysis (karyotyping)
- 8.4.2 Fluorescence in situ hybridization (FISH)
8.5 Microarrays
8.6 Gene expression profiling

Chapter 9 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Hospitals and clinics
9.3 Diagnostic laboratories
9.4 Forensic laboratories
9.5 Other end-users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
- 10.3.7 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Rest of Latin America
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa